版本:
中国

BRIEF-Jazz pharmaceuticals and Nippon Shinyaku enter into license agreements for development and commercialization of Defitelio and Vyxeos in Japan

March 30 Jazz pharmaceuticals:

* Jazz Pharmaceuticals Plc - co and Nippon Shinyaku enter into license agreements for development and commercialization of Defitelio and Vyxeos in Japan

* Jazz Pharmaceuticals - will manufacture, supply Defitelio and Vyxeos to Nippon Shinyaku; will receive revenue based on percent of product sales in Japan Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐